Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended to govern those capabilities are struggling to keep pace. AI company OpenAI ...
Transnational pharmaceutical companies want to do more clinical trials, and faster and cheaper. Private contract research organizations (CROs) have rapidly developed to meet this need by indentifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results